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Abstract
Neurobeachin (Nbea) regulates neuronal membrane protein trafficking and is required for the development and functioning of
central and neuromuscular synapses. In homozygous knockout (KO) mice, Nbea deficiency causes perinatal death. Here, we
report that heterozygous KO mice haploinsufficient for Nbea have higher body weight due to increased adipose tissue mass. In
several feeding paradigms, heterozygous KOmice consumedmore food than wild-type (WT) controls, and this consumption was
primarily driven by calories rather than palatability. Expression analysis of feeding-related genes in the hypothalamus and
brainstem with real-time PCR showed differential expression of a subset of neuropeptide or neuropeptide receptor mRNAs
betweenWT and Nbea+/2mice in the sated state and in response to food deprivation, but not to feeding reward. In humans, we
identified two intronic NBEA single-nucleotide polymorphisms (SNPs) that are significantly associated with body-mass index (BMI)
in adult and juvenile cohorts. Overall, data obtained in mice and humans suggest that variation of Nbea abundance or activity
critically affects body weight, presumably by influencing the activity of feeding-related neural circuits. Our study emphasizes the
importance of neural mechanisms in body weight control and points out NBEA as a potential risk gene in human obesity.
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Introduction
The BEACH (beige and Chediak-Higashi) domain protein family is
implicated in the intracellular targeting of membrane proteins. Its
members have been found in yeasts, amoebas, plants and animals,
suggesting involvement in fundamental cellular functions. Mutations
in BEACH domain proteins result in complex defects of cellular
membrane dynamics and membrane protein targeting [1–5].
One of the eight mammalian BEACH proteins [5] is
Neurobeachin (Nbea), a 327-kDa molecule expressed in neurons
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and endocrine cells. Nbea contains a high-affinity binding site for
the type II regulatory subunit of protein kinase A (PKA) [6], which
classifies it as an A-kinase anchor protein (AKAP). AKAPs anchor
and concentrate the PKA holoenzyme at defined subcellular
locations, enhancing the efficiency and specificity of the interaction
of PKA with selected subsets of its target proteins [7].
Nbea is associated with polymorphic vesiculo-tubulo-cisternal
endomembranes and postsynaptic plasma membranes, and it is
found at high concentrations near the trans side of Golgi stacks.
Therefore, a role of Nbea in the post-Golgi sorting or targeting of
membrane proteins was proposed [6]. Nbea is essential for
synaptic neurotransmission at neuromuscular junctions (NMJ):
Nbea-null mice generated via coincidental insertion mutagenesis
die immediately after birth due to breathing paralysis caused by a
complete block of evoked transmission at NMJs [8]. In
independently derived Nbea KO mice, central neurons showed
impaired neurotransmission at both excitatory and inhibitory
synapses, lower synapse density and altered synaptic protein
composition while the lethal NMJ phenotype was also confirmed.
The electrophysiological phenomena at central synapses suggested
defects of both presynaptic neurotransmitter release and postsyn-
aptic response, e.g., through reduced neurotransmitter receptor
density [9].
Human data on NBEA are very limited, but heterozygous
disruptions in the NBEA gene have been linked with autism and
multiple myeloma. A de novo translocation in the NBEA gene was
detected in an autistic patient [10], and additional evidence linking
deletions of the chromosomal region containing NBEA to autism
has been found ([11]; OMIM 608049). Heterozygous deletions
involving NBEA were found in a subgroup of multiple myeloma
patients [12], and NBEA was shown to harbor a region of
enhanced chromosomal fragility [11,13].
Homozygous inactivation of the Nbea gene in mice results in
perinatal death, whereas heterozygous Nbea KO mice are viable
and fertile and do not display obvious abnormalities. The
association of heterozygous human NBEA mutations with autism
and cancer suggested that NBEA haploinsufficiency may produce
related phenotypes in mice, and we therefore investigated Nbea+/
2 mice in the phenotyping screen of the German Mouse Clinic
(GMC). While the possible involvement of Nbea in autism and
cancer requires further study, we unexpectedly found phenotypic
features of these mice implicating Nbea in energy balance
regulation: significantly greater body weight and adipose tissue
mass and an elevated energy surplus during early life. Subse-
quently, we detected alterations in feeding behavior of Nbea+/2
mice in several functional tests investigating the effects of high
caloric and highly palatable diets, and in the expression of feeding-
related genes in the hypothalamus. Finally, we detected the
association of two intronic NBEA single-nucleotide polymorphisms
(SNPs) with weight and body mass index (BMI) in humans,
suggesting that variability within the NBEA gene may be a genetic
risk factor in human obesity.
Results
Haploinsufficient Nbea+/2 mice on standard chow
display faster increase in body weight due to moderately
elevated adiposity
The Nbea gene-trap KO allele has been described [9]. Mice
heterozygous for this allele are viable and fertile and display no
obvious abnormalities in observation up to an age of 2 years. We
did not observe the dwarfism described by Su et al. [8] for their
Nbea+/2 mice. This phenotypic aspect of the mutants of Su et al.
may be due to the specific nature of their mutation (antisense-
oriented insertion of a growth hormone minigene). Immunoblot
analysis of brain homogenates showed that Nbea protein
expression in Nbea+/2 mice was ,50% of wild-type (WT) mice
(4266% [mean6SEM], n = 12) whereas the expression level of
the Nbea isoform, Lrba, was unaffected (Figure 1A).
Nbea+/2 mice were systematically analyzed for genotype effects
in the primary phenotyping screen at the GMC. Mutant and
control mice entered the screen at an age of 9 weeks and were
consecutively investigated in the behavior, neurology, dysmor-
phology, clinical chemistry and energy metabolism screen, among
others [14–15]. Both male and female mutant mice were slightly
but significantly heavier than controls. Dual-energy X-ray
absorptiometry (DXA) performed on 16 weeks old WT and
Nbea+/2 mice revealed that the difference in body weight was due
to increased body fat content (Table 1). This increased adiposity
was apparent in both females and males.
As part of the first-line phenotyping screen we then determined
food intake and efficiency of energy extraction from the diet in
cohorts of 7 mice over 5 days at the age of 18–20 weeks, with ad
libitum access to standard chow (Table 1). At this stage food intake
was higher in Nbea+/2 mice (p,0.05) but proportional to body
mass; if initial body mass was included as a covariate, the statistical
analysis detected no genotype effect on food intake. The overall
efficiency of energy extraction from food (food assimilation
coefficient) did not differ between genotypes. Daily metabolized
energy intake was indistinguishable between the two genotypes
when adjusted for body weight.
Behavioral analysis of spontaneous activity in a novel environ-
ment, measured by the modified Hole Board test at age 8–9 weeks,
and neurological analysis according to a modified SHIRPA
protocol at age 9–10 weeks, did not indicate reduced spontaneous
activity that could cause lower energy expense of the Nbea+/2
mice. In particular, no reductions of motor activity parameters
(e.g., total distance moved) were detected. The only genotype-
related abnormality was a slight increase of mean locomotion
velocity in both sexes by an average 6.5% (genotype effect,
p,0.05), which may indicate a minor perturbation of the
locomotor rhythm generator and would, if at all, cause an
increased energy expense.
Author Summary
Body weight and energy balance are under very complex
neural, endocrine, and metabolic control. Correspondingly,
recent research suggests that hundreds of genes contrib-
ute to human obesity and that only a small proportion of
them have as yet been identified. Neurobeachin (Nbea) is a
protein specifically expressed in nerve and endocrine cells
and is important for neurotransmission, apparently by
influencing the synaptic targeting of membrane proteins.
Here, we show that heterozygous knockout mice, express-
ing Nbea at 50% of normal levels, display increased
adipose tissue mass, abnormal feeding behavior, and
modified expression of specific genes in the brainstem and
hypothalamus known to be important for body weight
control. Moreover, we find that NBEA gene polymorphisms
are associated with body-mass index in adult and juvenile
human cohorts. Our results demonstrate that variation of
Nbea activity critically affects body weight, presumably by
influencing the activity of feeding-related neural circuits.
They emphasize the importance of neural mechanisms in
body weight control, and they identify NBEA as a potential
genetic risk factor in human obesity.
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Blood chemical parameters determined at the ages of 12–13 and
17–18 weeks yielded a slightly increased a-amylase activity in both
sexes by an average 8% as the only parameter significantly
(p,0.05) and reproducibly abnormal in the mutants (age 12–13
weeks: males, WT 2640690 vs. Nbea+/22790660; females, WT
1940650 vs. Nbea+/2 2130640; in U/L6SEM). Sodium,
potassium, calcium, chloride, inorganic phosphate, creatinine,
triglycerides, cholesterol, urea, uric acid, glucose, total protein,
creatine kinase, alanine aminotransferase, aspartate aminotrans-
ferase, alkaline phosphatase, ferritin, transferrin and lipase were
unaffected by genotype.
In a second cohort of mice we monitored body mass and body
composition weekly during early lifetime. We could confirm the
development of mild obesity both in Nbea+/2 males and females
(Figure 1B–1D). To evaluate daily energy balance, we monitored
both sides of the energy balance equation, i.e. food intake and
Figure 1. Nbea-haploinsufficient mice develop higher body weight due to higher adipose tissue mass. (A) Western blot analysis of
whole brain demonstrates that Nbea protein expression in Nbea+/2 mice is half of that in WT mice. The same blot was sequentially developed with
anti-Nbea, anti-Lrba and anti-Cadherin. 1, K andJ indicate a dilution series of loaded protein. (B) Male and female Nbea+/2 mice develop higher
body mass than WT controls. From week 14 on we continuously detected a significant genotype effect on body mass in males and females combined
(week 14–15 p,0.05, week 16–19 p,0.01, afterwards p,0.001). (C,D) qNMR scans of mice aged 6–22 weeks shows that increased body mass of
Nbea+/2 mice is caused by increased fat tissue mass (significant genotype effect in females between week 6–21, in males in week 13–16, linear
model with body mass as covariate). (E) The in-out-difference between daily metabolizable energy and daily energy expenditure was significantly
increased in Nbea+/2 mice at the age of 8 weeks. (F) Plasma insulin and (G) leptin at 22 weeks of age were significantly increased in Nbea+/2 mice.
(H,I) High-fat feeding from age 14 weeks accelerates weight gain, more pronouncedly in Nbea+/2 than in WT mice. * within males, +within females,
P,0.05; ** within males, ++within females, P,0.01; *** within males, +++within females, P,0.001; error bars,6 SEM. In part H, all genotype differences
were significant for males with at least P,0.05 (except weeks 22 and 7, n.s.) and for females with at least P,0.001 (except week 22, p,0.01).
doi:10.1371/journal.pgen.1002568.g001
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energy assimilation and energy expenditure, by gas exchange
measurements over 24 hours at eight weeks of age. Indirect
calorimetry did not reveal statistically significant differences in
daily energy expenditure (Table 2). Monitoring of food intake and
bomb calorimetry of feces and diet samples to determine caloric
uptake and the amount of metabolizable energy indicated that
energy uptake was slightly increased in mutant animals but the
difference did not reach statistical significance when analyzed by a
linear regression model including genotype, sex and body mass
(Table 2). Calculating the difference between daily metabolizable
energy and daily energy expenditure showed that both WT and
Nbea+/2 mice were in a positive energy balance at 8 weeks of age
(Table 2 and Figure 1E). In WT mice this surplus of energy,
expressed as in-out difference in Table 2, was in the range of
,15 kJ per day reflecting the normal energy demand for growth
in 8 weeks old mice. Notably, the surplus of energy in Nbea+/2
mice was slightly higher with ,18 kJ per day. When compared to
WT mice, Nbea+/2 mice had 3.2 kJ (females) and 3.4 kJ (males)
excess energy available on a per day basis (Table 2). This effect of
genotype was significant when body mass changes during the
indirect calorimetry trial were included in the linear regression
model. Continuous monitoring of spontaneous motor activity
(distance traveled, rearing) and determination of body temperatures
again ruled out both parameters as explanations for the increased
fat mass and positive energy balance of Nbea+/2 mice (Table 2).
Plasma insulin (males +146%, females +29%, genotype p = 0.013)
and leptin levels (males +122%, females +131%, genotype
p = 0.002), determined at 22 weeks of age, were significantly
increased in Nbea+/2 mice (Figure 1F, 1G). When adjusted for
body fat content, however, no difference in leptin levels could be
detected. Resistin and PAI-1 were not different between genotypes.
Several mouse models for obesity exhibit normal or only slightly
increased body weight on standard diets but develop increased
adiposity in response to high-fat (HF) diet intake [16]. Therefore,
Table 1. First-line phenotyping in the German Mouse Clinic: Body composition (DXA) and energy assimilation parameters of 18–20
week-old WT and Nbea+/2 mice, fed with standard chow ad libitum over 5 days (n = 7/group for energy metabolism, n = 15/group
for DXA; means6SD).
Parameter Males Females P value genotype
WT Nbea+/2 WT Nbea+/2
Initial body mass (g) 30.860.8 32.260.9 23.260.7 25.961.0 ,0.05
Body fat mass (g) 6.760.9 9.261.9 3.760.9 7.361.0 ,0.05*
Lean mass (g) 20.961.1 19.861.5 16.660.7 15.0360.5 0.05*
Food intake (g/day) 3.560.5 4.160.4 3.260.4 3.360.3 n.s.*
Feces production (g/day) 0.7560.12 0.8660.12 0.6760.08 0.7360.07 ,0.05**
Energy content of feces (kJ/g) 15.5560.09 15.3060.21 15.4760.12 15.4460.12 ,0.05
Daily metabolized energy (kJ) 49.567.6 59.165.7 45.767.4 46.164.9 n.s.*
Food assimilation coefficient (%) 79.560.7 80.561.4 79.962.8 79.060.8 n.s.
Rectal body temp. (uC) 35.7560.14 35.9560.23 36.4560.27 36.4660.14 0.199
*Fat and lean mass, food intake and daily metabolized energy were analyzed using a linear model including body mass as covariate.
**Feces production was analyzed using a linear model including food intake as covariate to adjust for differences in overall food consumption.
doi:10.1371/journal.pgen.1002568.t001
Table 2. Energy balance and motor activity of 8 week-old WT and Nbea+/2 mice, fed with standard chow ad libitum over 24 h
(n = 8/group; mean6SD).
Parameter Males Females P value genotype
WT Nbea+/2 WT Nbea+/2
Body mass (g) 23.761.3 24.161.3 19.261.6 19.962.6 n.s.
Food intake (g/day) 4.760.6 5.060.5 4.560.4 4.760.7 n.s.*
Daily metabolized energy (kJ) 60.667.9 65.466.5 58.164.8 61.268.6 n.s.*
Oxygen consumption (ml/h) 91.463.7 94.064.8 85.760.6 85.365.8 n.s.*
Respiratory exchange ratio 0.9460.02 0.9560.01 0.9560.01 0.9760.03 n.s.
Daily energy expenditure (kJ) 45.761.9 47.162.3 43.064.3 42.963.0 n.s.*
In-out difference (kJ) 14.967.8 18.366.7 15.164.3 18.366.7 0.016**
Distance travelled (m/d) 398687 385688 5706252 4506152 n.s.
Rearing activity (counts/d) 701062242 617762510 950064174 11153613813 n.s.
Rectal body temp. (uC) 35.860.4 36.160.4 36.160.2 36.460.2 0.068
*Food intake, daily metabolized energy intake, oxygen consumption and daily energy expenditure were analyzed using a linear model including body mass as covariate
accounting for the effects of body mass differences on energy metabolism parameters.
**In-out difference was analyzed using a linear model including weight changes during the indirect calorimetry trial as covariate.
doi:10.1371/journal.pgen.1002568.t002
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Nbea+/2 and WT mice were fed a HF diet (60 energy% fat) from
the age of 14 weeks. In this third cohort of mice, Nbea+/2 males
and females weighed, respectively, 2.0 g and 3.6 g more than WT
mice at the onset of HF feeding, again confirming the body mass
phenotype. In response to HF feeding, Nbea+/2 females, in
particular, exhibited increased susceptibility to diet-induced
obesity. After 7 weeks of HF feeding Nbea+/2 females gained
substantially more weight than WT (4.1 g), whereas the differential
weight gain of Nbea+/2 males in excess of WT was marginal
(0.6 g) (Figure 1H, 1I). A glucose tolerance test after 22 weeks
revealed no genotype effects on baseline glucose level or glucose
response, in males or females (not shown).
Nbea+/2 mice overeat when motivated by hunger or by
the diet’s incentive combination of energy and
palatability, but not by palatability alone
As the previous experiments detected mild differences in gross
energy balance between Nbea+/2 and WT mice, we tested for
more subtle modifications of feeding behavior in episodic feeding
paradigms. During these tests, male mice were between the 8th and
10th week of age, before the emergence of a statistically significant
body weight difference between the genotypes. Although, at this
age, Nbea+/2 mice did not consume detectably more standard
chow when fed ad libitum (Nbea+/2: 174.861.0 g/kg body weight;
WT: 17762.3 g/kg body weight), the combined incentive of high
calorie content and palatability of a high-fat/high-sugar (HFHS)
diet stimulated them to eat significantly more than WT controls
(Figure 2A). When refed after overnight food deprivation, Nbea+/
2 mice ingested more also of the standard chow (Figure 2B).
Similarly, daily consumption of caloric palatable fluids (Intralipid
fat emulsion, sucrose, glucose, fructose) was higher in Nbea+/2
than in WT mice (Figure 2C). In contrast, non-caloric yet
palatable tastants (saline, saccharin, sucralose) were not overcon-
sumed by the Nbea+/2 animals (Figure 2D).
Nbea+/2 mice are leptin-responsive and naltrexone-
hyperresponsive
Obesity may be caused by leptin resistance. Resistant animals
injected with leptin prior to a meal do not reduce food consumption.
When we treated overnight-deprived Nbea+/2 mice with leptin at
the time of chow refeeding, they ate significantly less food than
control animals receiving only saline injection (Figure 2E), indicat-
ing that leptin resistance is unlikely to explain the obesity of Nbea+/
2 mice. Resistance to leptin is also marked by the lack of
responsiveness of hypothalamic neurons, which relay the effects of
leptin at the central level, to hormone infusion. A preliminary c-Fos
induction experiment (Figure S1) showed that leptin infusion
increased the density of Fos-immunopositive, activated neurons in
the arcuate nucleus (ARC) of an Nbea+/2 and a WT mouse alike,
confirming that the mutant mice are sensitive to leptin.
An anorexigenic dose of the opioid receptor antagonist,
naltrexone (NTX), administered peripherally to overnight-de-
prived mice just prior to chow refeeding, caused a ,30%
reduction in food intake in WT animals. Nbea+/2 mice consumed
,60% less food than saline controls (Figure 2F), showing that they
are responsive to NTX, indeed even hyperresponsive (p = 0.04).
Hypothalamic expression of genes involved in feeding
regulation differs between Nbea+/2 and WT mice in the
baseline sated state and in the hungry state, but not
upon intake of palatable foods
Following the identification of altered feeding behavior
described above, we hypothesized that reduced Nbea expression
may alter the activity of neuronal networks involved in energy
balance control. We investigated whether expression of feeding-
related genes differs between the Nbea+/2 and WT genotypes in
response to different food availability/quality regimens: in ad
libitum feeding of standard chow, following food deprivation, and
when a palatable diet is offered. Ad libitum-fed Nbea+/2 mice
expressed a higher level of orexigenic dynorphin (DYN) mRNA
compared to WT controls in the hypothalamus (Figure 3A).
Moderate-length (16 h) food deprivation led to higher mRNA
expression of four hypothalamic genes in Nbea+/2 vs. WT mice.
Three of them: DYN, proopiomelanocortin (POMC) and opioid-
like receptor-1 (ORL1), are linked with orexigenic responses
(POMC gives rise to orexigenic beta-endorphin, but also to
hypophagic melanocortins (MC)), whereas corticotropin releasing
hormone (CRH) is involved in the HPA axial activity and satiety
signaling. In the brainstem, only the MC3 receptor mRNA level
was lower in Nbea+/2 than in WT mice in the ad libitum paradigm,
and none of the markers were differentially affected by food
Figure 2. Differential feeding behavior of Nbea+/2 and WT
mice. Male mice were tested at the age of 8–10 weeks, prior to the
manifestation of a significant body weight difference between the
genotypes. Compared to WTmice, Nbea+/2mice (A) ate more ad libitum
of the energy-dense and palatable high-fat high-sugar (HFHS) solid diet;
(B) ate more standard chow upon 2-h refeeding after overnight food
deprivation; (C) consumed more of the caloric and palatable 4.1%
Intralipid, 10% sucrose, 10% glucose and 10% fructose solutions; but (D)
they consumed the same amounts of tastants which do not contain
calories, i.e. saline, 0.1% saccharin or 0.05% sucralose, despite their
palatability. Nbea+/2mice (E) were not resistant to leptin, but they were
(F) more sensitive to the anorexigenic naltrexone (NTX) than their WT
counterparts. *, P,0.05; **, P,0.01; ***, P,0.001; error bars, 6 SEM.
doi:10.1371/journal.pgen.1002568.g002
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deprivation (Figure 3B). Animals exposed to the palatable diet did
not show any difference between genotypes in their gene
expression response in the hypothalamus (Figure 3C).
NBEA gene polymorphism is associated with body-mass
index (BMI) in human cohorts
We then examined whether the link between Nbea and body
weight control identified in the mouse model can be extended to
humans. We studied the association of two relatively common
SNPs with body weight and BMI. Two intronic SNPs in NBEA,
rs17775456 and rs7990537 (r2 = 0.12), were genotyped in two
cohorts: one comprising adult men from the ULSAM cohort and
one case-control cohort of children and adolescents. Table 3 shows
anthropometric characteristics in the two cohorts according to
NBEA rs17775456 and rs7990537 genotype and weight status.
None of the two SNPs caused deviation from Hardy-Weinberg
equilibrium in any of the studied cohorts (p.0.05). We analyzed
the subjects for associations with overweight and obesity
depending on NBEA genotypes (Table 4) as well as BMI and
weight as continuous traits (Table 5). We found a significant
association for rs17775456 and rs7990537 with BMI as a
continuous trait (rs17775456: p = 0.001 and rs7990537:
p = 0.006) and trends for weight (rs17775456: p = 0.022 and
rs7990537: p = 0.025) among the overweight adult men. Carriers
of the minor allele were heavier and had higher BMI than non-
carriers. Among children and adolescents, we found that
rs7990537 was significantly associated with BMI in the normal-
weight children, the carriers of the minor allele again having
higher BMI standard deviation scores (SDS).
Discussion
For years, obesity research focused primarily on ligand-receptor
interactions as the basis of feeding and metabolic responses.
Consequently, improper functioning of the ligand-receptor system
was considered a causative factor underlying dysregulation of body
weight. While this holds true for many such systems, including
melanocortins, leptin, ghrelin and neuropeptide Y [17–20], it has
become clear that molecules which are not directly involved in
communication at the cell surface, but are part of intracellular
mechanisms, e.g., the nucleic acid demethylase Fto, also play a
crucial role in the control of energy homeostasis [21]. Here, we
report a combination of mouse and human data pertaining to
Nbea, a regulator of membrane protein trafficking, showing that
mice heterozygous for the Nbea KO allele develop an obese
phenotype and that two intronic NBEA SNPs are associated with
weight and BMI in humans. Nbea is one of a growing number of
proteins important for synaptic development and function that is
also associated with obesity. Changes in the Nbea status appear to
affect select metabolic and feeding-related parameters.
Nbea+/2 mice develop moderately elevated body weight during
early adulthood. Body composition analyses show that this higher
body weight stems from increased adipose tissue mass. Lean mass
is virtually unaffected (slightly lower in the experiment of Table 1,
slightly higher in the experiment of Figure 1D), suggesting altered
partitioning of energy in these animals in favor of energy
preservation and storage. Therefore, the phenotype of the
Nbea+/2 mouse can be defined as mildly obese. Increased insulin
levels are consistent with this phenotype. Clinical chemistry
parameters were otherwise unremarkable, except for a small
increase of a-amylase activity in plasma. Leptin levels in Nbea+/2
mice were increased only in proportion to the higher body fat
content, and these animals were not leptin-resistant just prior to
the onset of the overweight phenotype, as demonstrated by their
hypophagia and c-Fos induction in response to leptin administra-
tion. At the age of 16 to 18 weeks Nbea+/2 mice fed ad libitum
consumed standard chow in greater quantities and exhibited
higher daily metabolizable energy intake as compared to WT mice
(Table 1), but only in proportion to body mass [22]. Reduced
locomotor activity or body temperature as possible explanations of
weight gain could not be detected, neither in the primary
phenotyping (Table 1) nor in the experiment of Table 2. Rather,
also in additional measurements, body temperature always tended
Figure 3. Differential expression of feeding-related genes in
Nbea+/2 and WT mice under different feeding paradigms. Ad
libitum-fed, sated Nbea+/2 and WT mice showed a differential
expression of the dynorphin (DYN) mRNA in the hypothalamus (A)
and of the melanocortin (MC) receptor-3 mRNA in the brainstem (B). 16-
h food deprivation differently affected expression of mRNAs encoding
DYN, proopiomelanocortin (POMC), opioid-like receptor-1 (ORL1) and
corticotropin releasing hormone (CRH) in the hypothalamus (A),
whereas no differences between the genotypes were triggered by
food deprivation in the brainstem (B). Exposure to the palatable HFHS
diet did not affect gene expression differently in the Nbea+/2 and WT
animals. Only DYN mRNA was increased in the standard chow-fed
controls (C). * P,0.05; error bars, 6 SEM. The following other genes
were also analyzed, but their expression levels did not differ between
the genotypes: AGRP, Agouti-related protein; AVP, vasopressin; CCK,
cholecystokinin; CRHR, CRH receptor; DOR, delta opioid receptor; ENK,
enkephalin; GHSR, growth hormone secretagogue receptor; GLP1R1,
glucagon-like peptide 1 receptor 1; KOR, kappa opioid receptor; MCH,
melanin concentrating hormone; MOR, mu opioid receptor; NPY,
neuropeptide Y; ORX, orexin.
doi:10.1371/journal.pgen.1002568.g003
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to be increased. Taken together, our primary screen data did not
reveal an explanation for the development of mild obesity in
Nbea+/2 mice.
Metabolic abnormalities in mildly obese mice, such as Nbea+/2,
are very small and difficult to detect in whole body energy balance
studies. It has been pointed out that the statistical power required
to detect a slight but relevant imbalance between energy intake
and expenditure is usually not attained with the small cohort sizes
used in most animal experimentation [23]. We therefore
conducted a second, more detailed analysis of whole body energy
balance in a new cohort of mice just before the emergence of
increased body fat accumulation. Energy assimilation and energy
expenditure were monitored in parallel, but neither parameter as
such was significantly altered. However, we found a small but
significant elevation of the in-out difference of both parameters in
Nbea+/2 as compared to WT mice. In terms of absolute surplus
energy gain the higher in-out-difference of about 3 kJ per day in
Nbea+/2 mice is sufficient to build up excess fat stores of about 1 g
over less than two weeks [23].
Notably, an increased drive to consume food was revealed in the
Nbea+/2 mice by presenting them with a defined meal of standard
chow following a single period of mild food deprivation. Nbea+/2
animals ingested significantly more calories than WTs even though
no detectable difference in body weight between the mutant and
WT animals had as yet developed. Therefore heterozygotes have a
higher baseline consumption reflecting their elevated body weight
and additionally, under certain food availability conditions, they
are more prone to episodic overeating that exceeds the body
weight-adjusted control values. In line with this, our data on liquid
diet intakes indicate that Nbea+/2 animals, regardless of their
energy status (i.e., hungry or sated), episodically overconsume
tastants providing energy, as evidenced by our finding that non-
deprived heterozygotes ingest more calorie-containing solutions of
sucrose, glucose, fructose or a lipid emulsion (Intralipid) than WTs.
An increase is also observed upon ad libitum exposure to high-fat
high-sugar chow. It is important to note that this elevated intake of
solid and liquid diets does not appear to be primarily driven by an
increased response to food reward. While palatability serves as a
co-stimulus to ingest food, the absence of calories prevents
Table 3. Anthropometric characteristics in 50 year-old men
and children stratified according to weight status and NBEA
rs17775456 and rs7990537 genotype.
rs17775456 TT TA AA
Normal weight adult men, n = 597 2 85 510
Weight (kg) 71.666.8 70.367.0 67.067.1
BMI 22.261.7 22.161.4 21.061.4
Overweight adult men, n = 497 2 54 441
Weight (kg) 93.0618.4 85.669.6 84.767.8
BMI 29.065.7 27.462.5 26.762.1
Normal-weight children, n = 520 3 76 441
Weight (kg) 64.7610.1 61.769.4 63.9610.0
BMI SDS 0.33060.581 0.02660.480 0.17360.588
Obese children, n = 499 3 54 442
Weight (kg) 111.0642.3 91.6629.9 91.4628.9
BMI SDS 7.560.7 5.961.5 5.761.5
rs7990537 GG GA AA
Normal weight adult men, n = 609 20 211 378
Weight (kg) 71.866.9 68.969.0 71.166.4
BMI 22.162.7 21.861.9 22.361.5
Overweight adult men, n = 507 18 146 343
Weight (kg) 87.2611.1 85.868.0 84.167.9
BMI 28.063.1 27.062.1 26.762.0
Normal-weight children, n = 520 17 179 324
Weight (kg) 65.469.2 63.8610.3 62.969.3
BMI SDS 0.18360.581 0.10760.577 20.06260.442
Obese children, n = 501 23 166 312
Weight (kg) 94.7631.2 89.5620.0 89.6628.4
BMI SDS 5.961.9 5.761.5 5.761.4
Data are means 6 SD divided into genotype groups.
doi:10.1371/journal.pgen.1002568.t003
Table 4. Odds ratio for overweight and obesity depending on NBEA genotypes in adults and children.
N Genotype, n (%) MAF % OR (95% CI) P
Adults G1 G2 G3 GRR (95% CI)
rs17775456 Normal weight 561 2 (0.4%) 64 (11.4%) 495 (88.2%) 6.0 1.241 (0.887–1.735) 0.207
A.T Overweight 533 2 (0.4%) 75 (14.1%) 456 (85.5%) 7.0 1.22 (0.904–1.669)
rs7990537 Normal weight 574 20 (3.5%) 169 (29.4%) 385 (67.1%) 18.0 1.170 (0.949–1.444) 0.142
A.G Overweight 542 18 (3.3%) 188 (34.7%) 336 (62.0%) 21.0 1.161 (0.991–1.360)
N Genotype, n (%) MAF % OR (95% CI) P
Children G1 G2 G3 GRR (95% CI)
rs17775456 Normal weight 520 3 (0.6%) 76 (14.6%) 441(84.8%) 7.0 0.747 (0.529–1.055) 0.706
A.T Obese 499 3 (0.6%) 54 (10.8%) 442(88.6%) 6.0 0.752 (0.547–1.033)
rs7990537 Normal weight 520 17 (3.3%) 179 (34.4%) 324 (62.3%) 20.5 1.042 (0.842–1.290) 0.097
A.G Obese 501 23 (3.3%) 166 (34.4%) 312 (62.3%) 21.2 1.000 (0.854–1.172)
Data are number of subjects in each group and number of subjects for each genotype (G) (% in each group). Allele frequency (A) for each group is given in percentage.
GRR indicate genotype relative risk with a 95% confidence interval (CI). Odds ratio (OR) with a 95% confidence interval (CI) was calculated assuming an additive model.
Association with overweight in the adult cohort was determined comparing subjects with normal weight (BMI,25 kg/m2) and overweight (BMI$25 kg/m2). P indicates
p-values adjusted for age and gender.
doi:10.1371/journal.pgen.1002568.t004
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heterozygotes from consuming more than WTs even when the
level of feeding reward is high, as Nbea+/2 and WT mice did not
differ in the amount of ingested non-caloric tastants, including
palatable saccharin, sucralose and saline.
As Nbea has been shown to be involved in development of and
neurotransmission within brain networks [9], we investigated the
potential influence of Nbea haploinsufficiency on brain mecha-
nisms pertaining to energy balance. Our gene expression data
suggest changes in the activity of the circuitry governing energy
homeostasis. Sated Nbea+/2 animals overexpress orexigenic DYN
in the hypothalamus. This may predispose them to eating more
upon exposure to caloric foods of desirable characteristics (e.g.,
palatability, texture). An increased sensitivity of Nbea+/2 mice to
naltrexone in the feeding model strengthens the link between the
opioid system and dysregulation of energy balance in Nbea
haplosufficiency. DYN, which mediates maintenance of feeding as
well as reward [24,25], is a plausible candidate for such a function.
Negative energy balance induced by food deprivation led to
increased expression of as many as four hypothalamic genes in
Nbea+/2 compared to WT mice. Two of them, DYN and ORL1,
encode orexigens [24,26,27]. This suggests an enhanced sensitivity
of the hypothalamic feeding circuitry to calorie deprivation in
Nbea+/2 mice, associated with upregulated expression of
neuropeptides which stimulate feeding. Since POMC codes for
anorexigenic melanocyte stimulating hormone, changes in its
expression may also reflect a compensatory mechanism in
response to a positive energy balance in the mutant. In contrast
to the findings in the deprived and sated state, exposing animals to
the palatable diet did not cause differential expression of any gene
between Nbea+/2 and WT mice in the hypothalamus.
We searched HapMap (www.hapmap.org) for SNPs in the
human NBEA gene with the aim to genotype a frequent SNP as
well as a rare SNP that could have a higher penetrance than a
common SNP. NBEA is a large gene, ,730 kb, and based on
HapMap data the gene contains over 30 haplotype blocks. The
two SNPs we selected, rs17775456 and rs7990537, are part of two
separate haplotype blocks spanning around 261 and 54 kb,
respectively. These SNPs were genotyped in two cohorts: one
consisting of severely obese Swedish children and adolescents
(mean age 12.663.3 years and mean BMI SDS 6.261.4) and their
age-matched normal-weight controls, and another one of Swedish
men born 1920–1924, thus reaching adulthood prior to the
appearance of today’s obesogenic environment. Individuals in
both cohorts showed a significant association of NBEA polymor-
phism with BMI. We found associations for both, rs17775456 and
rs7990537, with both body weight and BMI in overweight adult
men, while one of the SNPs showed association with BMI in the
normal-weight children. In both cohorts, the same allele was
associated with high BMI. No genetic variants in NBEA have
previously been reported to be associated with obesity. However,
one of the latest papers on novel loci for BMI [28] estimates that
there are at least an additional 300 undiscovered variants that can
be linked to obesity. In addition, according to data on 1479
subjects from the British 58 Birth Cohort (www.b58cgene.sgul.ac.
uk/index.php) six SNPs in the two haplotype blocks harboring our
SNPs are nominal associated with BMI at the age of 44–45 with
the same effect direction. This suggests that NBEA may be linked
to a moderately adipogenic activity which, in children, is better
detectable in a normal-weight than in a severely obese back-
ground, and only manifests as overweight at an adult age.
We conclude that neural circuitries involved in food intake and
body weight control are sensitive to moderate variation of Nbea
activity such as haploinsufficiency. Morphological and electro-
physiological abnormalities of cortical neurons have indeed been
detected in Nbea+/2 mice [29]. The reduction of Nbea expression
by only 50% suffices to cause monogenic adiposity, at least in the
mouse model and the C57BL/6N genetic background. This points
out human NBEA as a potential genetic factor in common,
polygenic obesity in collusion with additional genes. Even more
subtle variations of NBEA expression, activity or regulation may
contribute to polygenic obesity, as a risk or protective factor. The
NBEA gene is very large (730 kb, 58 exons) and recombination-
prone [13], offering extensive mutation potential.
Recent genome-wide association studies emphasize the high
proportion of neuronally expressed genes implicated in obesity.
Indeed, human obesity has been characterized as ‘‘a heritable
neurobehavioral disorder that is highly sensitive to environmental
conditions’’ [30]. Our characterization of the obese Nbea+/2
phenotype is a case in point for both parts of this statement. Nbea
is expressed in apparently all neuronal and endocrine cell types [6]
and probably has a broad importance for nervous system
development and function [9]. In spite of this pleiotropy, the first
macroscopic manifestation of Nbea haploinsufficiency to be
detected in mice is an impact on body weight, reflecting the
subtlety and vulnerability of the neural control of energy balance.
Moreover, our findings that the Nbea+/2 mice are more prone
than WT mice to respond to episodic feeding paradigms by
overconsuming can be seen as a perturbed ability to handle
nutritional challenges, an important factor also in human obesity.
It is intriguing that heterozygous perturbations of the NBEA
gene have been linked to three dissimilar medical conditions:
autism, multiple myeloma, and now obesity. Whereas involve-
ments in autism and obesity may be explained by impacts of
NBEA underexpression on the development or functioning of
different neuronal circuitries, the association with cancer may be
due to functional overlap with its ubiquitous isoform, LRBA [31].
Table 5. Association with BMI and body weight as continuous traits in adults and children for NBEA rs17775456 and rs7990537.
Adult Children
SNP Phenotype Overweight Normal-weight Obese Normal-weight
Beta PAdd Beta PAdd Beta PAdd Beta PAdd
rs17775456 Body weight (kg) 0.014 0.022 0.013 0.164 0.823 0.487 1.358 0.330
BMI 0.151 0.001 20.072 0.208 0.196 0.353 0.188 0.435
rs7990537 Body weight (kg) 0.016 0.025 0.015 0.201 0.306 0.198 1.194 0.056
BMI 0.094 0.006 20.046 0.216 0.019 0.765 0.208 0.005
Beta indicates transformed beta-values. P indicates p-values adjusted for significant covariates.
doi:10.1371/journal.pgen.1002568.t005
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It seems to be a common feature of BEACH proteins that they are
involved in the targeting of multiple membrane proteins, and that
their KOs therefore generate pleiotropic but partial defects [9].
Autism, cancer and obesity all are typical polygenic disorders, and
in combination with different sets of additional risk genes, NBEA
misexpression may contribute to different manifestations.
Materials and Methods
Animals
Construction and genotyping of the Nbea gene-trap KO mice
has been described [9]. Analyses described here were performed
with animals after backcrossing into the C57Bl/6N background
for 5 generations or more. Animal experiments were performed at
the animal facilities of Uppsala University or the GMC at the
Helmholtz Zentrum Mu¨nchen, Germany. All studies received
prior approval from the local animal ethics committees and
adhered to the German, Swedish and EU laws pertaining to the
protection of animals.
Western blot analysis of Nbea expression
Immunoblots of 5% SDS-polyacrylamide gels were sequentially
probed with affinity-purified rabbit sera directed against isoform-
specific sequences of mouse Nbea and mouse Lrba generated in
our laboratory (S.S. & M.W.K.), and with an anti-pan-cadherin
mAb (Sigma C1821). Chemiluminescence-exposed X-ray films
were analyzed by densitometry. Whole-brain homogenates were
prepared from four animals of each genotype (aged 6 months),
adjusted for equal protein concentrations, and dilution series of all
four sample sets were analyzed twice by Western blotting and
densitometry. Nbea and Lrba signals of each lane were normalized
on the respective cadherin control signal.
Body composition, energy metabolism, and clinical
chemistry
Metabolic functions of WT and Nbea+/2 mice were charac-
terized in a comprehensive systemic phenotyping screen [14,15].
In total, 140 mice entered the GMC in three cohorts. The primary
screen was conducted using the first cohort of 60 mice (n = 15 per
sex and genotype for clinical chemistry [tested at 12–13 and 17–18
weeks] and DXA [age, 16–18 weeks]; a subsample of n = 7 mice
per sex and genotype in the energy metabolism screen). Groups of
up to four mice per cage were housed on a 12-h light/dark cycle,
had ad libitum access to regular laboratory chow (Altromin1324;
Altromin, Lage, Germany), and were provided with UV-irradiated
and micro-filtered tap water. For energy assimilation monitoring
(age 18–20 weeks), mice were single-caged on grid panels (0.5-cm
grid hole diameter) allowing the collection of feces and spilled food
of individual mice. Body weight, food consumption, mean rectal
body temperature of five consecutive measurements conducted at
10 a.m. every day, daily feces production calculated from a five-
day pooled sample, energy uptake, energy content of the feces,
metabolizable energy and the food assimilation coefficient were
determined. Samples of the lab chow and feces (,1 g) were dried
at 60uC for two days, homogenized in a grinder and squeezed to a
pill for determination of energy content in a bomb calorimeter
(IKA Calorimeter C7000). Energy uptake was determined as the
product of food consumed and the caloric value of the food. To
obtain metabolizable energy, the energy content of feces and urine
(2% of energy uptake) was subtracted from energy uptake. Two-
way ANOVA (SigmaStat, Jandel Scientific) was used to test for
effects of the factors, genotype and sex. To adjust for body mass
differences in energy metabolism parameters, a linear regression
model was applied including body mass as a co-variate (TIBCO
Spotfire S+ 8.1 for Windows). A pDEXA Sabre X-ray Bone
Densitometer (Norland Medical Systems Inc., Basingstoke,
Hampshire, UK) was used for dual-energy X-ray absorptiometry
(DXA). The entire body area including and excluding the skull was
assayed with a 0.02-g/cm2 Histogram Averaging Width (HAW)
setting.
In the second cohort of mice (n = 10 per sex and genotype),
body composition was followed up by non-invasive qNMR scans
(MiniSpec LF60, Bruker Optics, Germany). For the evaluation of
energy balance, single mice were kept in respirometry cages
(Phenomaster System, TSE Systems, Germany) including the
monitoring of gas exchange, food and water uptake, and
locomotor activity. To convert food consumption into caloric
uptake, energy extraction efficiency of individual mice was
determined as described above. Li-heparin plasma samples for
clinical chemistry analyses were obtained by blood collection from
the retroorbital vein plexus of ether-(first cohort) or isoflurane-
anesthetized mice into heparinized tubes. Samples were mixed
thoroughly and stored for 2 h at room temperature before being
separated from blood cells by centrifugation (46566 g; 10 min).
Plasma samples were stored at 4uC and analyzed within 24 h using
an AU400 autoanalyzer (Olympus, Hamburg, Germany) and
adapted test kits from Olympus. Adipokine determinations were
performed with the LINCOplex mouse serum adipokine multiplex
immunoassay kit MADPK-71K-07. Two-way ANOVA (Sigma-
Stat, Jandel Scientific) was used to test for effects of genotype and
sex, and significance of mean differences between genotypes within
each sex was tested using the Welsh t-test (Excel, Microsoft).
HF feeding and glucose tolerance test
Beginning at the age of 14 weeks, a third cohort of mice (n = 10
per sex and genotype) were fed a HF diet (D12492, Research
Diets, New Brunswick NJ, USA) for further 24 weeks. 60% of the
total energy content (23.2 kJ g21) was due to fat (lard and soybean
oil). Mice were weighed every week. After 22 weeks, an
intraperitoneal glucose tolerance test was conducted after
overnight fasting according to the EMPReSSslim protocol (www.
eumodic.eu). Blood samples were taken from the tail vein prior,
15, 30, 60, 90, and 120 minutes after intraperitoneal injection of
the 2 mg per g body mass glucose bolus.
Episodic feeding experiments
Animals were housed individually in a temperature- (21–23uC)
and humidity-controlled facility with a 12:12 LD cycle (lights on at
06:00). Age-matched (62 days) males were used simultaneously.
Tap water and standard chow (Lactamin, Lidko¨ping, Sweden)
were available ad libitum unless specified otherwise. Sixteen age-
matched animals of each genotype were used in Experiments 1, 2
and 3, whereas 11 mice per genotype were included in Experiment
4. Mice were between the 8th and 10th week of age, before the
emergence of a statistically significant difference in body weight
between the genotypes: 18.060.4 g in heterozygotes and
17.560.3 g in WT controls.
Experiment 1: Effect of genotype on ad libitum
consumption of the energy-dense and palatable HFHS
(high-fat high-sugar) diet. Standard chow was removed
from cages at 09:00 and it was replaced with the palatable
HFHS pellets (Research Diets). During the first 24 h of exposure
to the HFHS food, the animals were allowed to get accustomed to
the new diet. Then the amount of ingested food (corrected for
spillage) was measured for the period of 24–72 h.
Experiment 2: Effect of genotype on food deprivation-
induced re-feeding. Standard chow was removed just before
the onset of darkness and it was returned at 10:00 on the
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subsequent day. The amount of ingested food (corrected for
spillage) was measured 2 h later when the major consummatory
activity had subsided.
Experiment 3: Effect of genotype on ad libitum
consumption of caloric and palatable Intralipid and sugar
solutions. Mice were given a bottle of 10% sucrose, 4.1%
Intralipid, 10% glucose or 10% fructose in addition to chow for
48 h. Intralipid (Fresenius, Sweden), a palatable lipid emulsion of
soybean oil, glycerol and egg yolk phospholipids, has been used in
experiments utilizing liquid diets [32]. Sucrose, glucose, fructose
and Intralipid were isocaloric (0.4 kcal/g), whereas the energy
content of chow was 3.6 kcal/g. During the first 24 h of exposure
to the liquids, the animals were allowed to get accustomed to the
new tastants. Uptake was measured during the following 24 h.
Experiment 4: Effect of genotype on ad libitum
consumption of non-caloric but palatable saccharin,
sucralose, and saline solutions. Mice were given a bottle of
0.1% saccharin, 0.05% sucralose or saline in addition to chow for
48 h. Total caloric intake per mouse in the saccharin paradigm in
heterozygotes was 12.5360.7 kcal and in WTs, 13.3960.5 kcal;
in the sucralose paradigm, heterozygotes ingested 14.8960.7 kcal
and WTs, 14.5360.5 kcal; in the saline paradigm, heterozygotes
ingested 13.1960.4 kcal and WTs, 13.2560.5 kcal. During the
first 24 h of exposure to the liquids, the animals were allowed to
get accustomed to the new tastants.
Experiment 5: Effect of leptin administration on
deprivation-induced food intake by Nbea+/2 mice. Chow
was removed from the hoppers of Nbea+/2 mice before the onset
of darkness. On the next day, at 11:00, the animals were injected
i.p. with 10 mg leptin or vehicle (n = 5/group) and the pre-weighed
food pellets were returned to the hopper. Food intake was
measured 3 h post-injections and corrected for spillage.
Experiment 6: Effect of naltrexone (NTX) on deprivation-
induced food intake. Chow was removed from the hoppers of
Nbea+/2 and WT mice before the onset of darkness. On the next
day, at 11:00, the animals were injected i.p. with 3 mg/kg NTX or
vehicle (n = 5–7/group) and the pre-weighed food pellets were
returned to the hopper. Food intake was measured 3 h post-
injections and corrected for spillage.
Real-time PCR analysis of expression of feeding-related
genes
Hypothalamic and brainstem gene expression after 16-h
food deprivation. Standard chow was removed just before the
onset of darkness and mice (n = 8/genotype) were decapitated
between 10:00 and 11:00 on the next day. The fed controls (n = 8/
genotype) had food ad libitum and were decapitated between 09:00
and 10:00. mRNA expression in the hypothalamus and brainstem
was studied with real-time PCR.
Hypothalamic Nbea expression following 48-h
consumption of the HFHS diet. Mice that had been pre-
exposed 5 days earlier to the HFHS food (Research Diets) for 1
day were given this diet again for 48 h; controls (n = 8/genotype)
had standard chow only. Mice were decapitated after 48 h
(between 10:00 and 11:00). mRNA expression in the
hypothalamus was studied with real-time PCR.
PCR methodology. Brains were excised, anatomical regions
of interest dissected, immersed in RNAlater (Ambion, USA), kept
at room temperature for 2 h and, thereafter, stored at280uC until
further processed. Samples were homogenized and RNA prepared
as previously described [33]. Relative expression levels of seven
housekeeping genes (glyceraldehyde-3-phosphate-dehydrogenase,
b-tubulin, ribosomal protein 19, histone H3, cyclophilin, b-actin,
and succinate dehydrogenase complex subunit B) and of the genes
of interest were determined with quantitative rtPCR. Each
reaction, with a total volume of 20 ml, contained 20 mM Tris/
HCl pH 9.0, 50 mM KCl, 4 mM MgCl2, 0.2 mM dNTP, DMSO
(1:20) and SYBR Green (1:50000). Template concentration was
5 ng/ml and the concentration of each primer was 2 pmol/ml.
Primers were designed with Beacon Designer (Premier Biosoft)
using the SYBR Green settings. All rtPCR experiments were
performed in duplicates; for each primer pair a negative control
with water and a positive control with 5 ng/ml of genomic DNA
were included on each plate. Amplifications were performed with
0.02 mg/ml Taq DNA polymerase (Biotools, Sweden) under the
following conditions: initial denaturation at 95uC for 3 min, 50
cycles of denaturing at 95uC for 15 sec, annealing at 52.8–60.1uC
for 15 sec and extension at 72uC for 30 sec. Analysis of rtPCR
data was performed as previously reported [34]. MyIQ 1.0
software (Bio-Rad) was used. Primer efficiencies were calculated
using LinRegPCR [35] and samples were corrected for differences
in primer efficiencies. The GeNorm protocol described by
Vandesompele et al. [36] was used to calculate normalization
factors from the expression levels of the housekeeping genes.
Grubbs’ test was used to remove outliers. Differences in gene
expression between groups were analyzed with ANOVA followed
by Fisher’s PLSD test where appropriate. P,0.05 was used as the
criterion of statistical significance.
Human genetic studies
Subjects. We genotyped 1152 men from the Uppsala
Longitudinal Study of Adult Men (ULSAM), described
previously [37–38]. The study was approved by the Ethics
Committee of the Department of Medicine, Uppsala University.
All participants gave their written informed consent. We further
genotyped 1027 children and adolescents comprising one group of
obese children and adolescents and one group of normal-weight
adolescents, as described earlier [39]. The study was approved by
the Regional Ethics Committee in Stockholm.
Phenotype characterization. For the men, height was
measured to the nearest whole centimeter and weight to the
nearest whole kilogram at age 50 years. BMI was calculated as
weight divided by height squared (kg/m2). For the children and
adolescents, body weight and height were measured to the nearest
0.1 kg and 1 cm, respectively. BMI standard deviation score (BMI
SDS) was calculated from weight and height and standardized for
age and sex [40].
Genotyping. Genotyping of NBEA rs7990537 and
rs17775456 variants in the ULSAM cohort was carried out at
the SNP technology platform at Uppsala University (http://www.
genotyping.SE/) using an Illumina Golden Gate Assay [41]. The
SNP genotype call rate in the samples was 96.8%. For the children
and adolescents, genomic DNA was extracted from peripheral
blood using QiaGen Maxiprep kit (Qiagen, Hilden, Germany).
Genotyping was performed with pre-designed Taqman single-
nucleotide polymorphism genotyping assay (Applied Biosystems,
Foster City, USA) and an ABI7900 genetic analyzer with SDS 2.2
software.
Statistical analysis. In order to test for deviation from
Hardy-Weinberg equilibrium, the Person’s x2-test (1 d.f) was
applied. Association analysis of rs17775456 and rs7990537 with
obesity measurements was performed using BMI and body weight
as continuous traits. The adult men were categorized as
overweight (BMI$25 kg/m2) or normal-weight (BMI,25 kg/
m2) before the analysis. Skewed variables were log-transformed
and analyzed with linear regression, assuming an additive model.
Covariates such as height, age and sex were tested for dependence
on the response variables and included in the model if significant.
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In order to correct for multiple comparisons Bonferroni correction
was applied and a p-value#0.006 was considered statistically
significant. All the analyses were performed using PLINK (http://
pngu.mgh.harvard.edu/purcell/plink/) [42].
Power analysis. Power calculation was carried out with the
CaTS power calculator (www.sph.umich.edu/csg/abecasis/
CaTS/index.html) [43] and Power and Sample Size Calculation
(biostat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize) [44].
For rs17775456 we had 80% power to detect association with
overweight and obesity, with a relative risk of 1.2. For rs7990537
we had 80% power to detect association with overweight and
obesity with a relative risk of 1.4.
Supporting Information
Figure S1 ARC neurons of Nbea+/2 mice are sensitive to leptin.
A: An intraperitoneal injection of leptin at the dose that reduces
food intake causes an increase in the density of Fos immunore-
active (IR) nuclei in the ARC of WT and Nbea+/2 mice
(established bilaterally per mm2 of the tissue on every fourth ARC
section). One animal per genotype was injected with saline or
leptin (treatment details as in the feeding experiment). An hour
later the mice were perfused transcardially with 4% paraformal-
dehyde. Coronal brain sections (50 mm) were cut on a vibratome
and immunostained. Images provided by the camera attached to
the Nikon microscope were analyzed using the NIH 1.51 Image
software (NIH, MD). Full description of Fos staining in [32]. B:
Photomicrographs depicting c-Fos staining in the ARC of saline-
(left) versus leptin-treated (right) Nbea+/2 mice. VMH, ventro-
medial hypothalamic nucleus; 3v, 3rd ventricle.
(TIF)
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